Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cerus Corporation (CERS)
:CERS
Holding CERS?
Track your performance easily
CERS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.38 - $2.59
Previous CloseN/A
Volume302.69K
Average Volume (3M)1.33M
Market Cap
$338.00M
Enterprise Value$345.76M
Total Cash (Recent Filing)$71.63M
Total Debt (Recent Filing)$12.44M
Price to Earnings (P/E)―
Beta2.79
Next Earnings
Feb 20, 2025EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding185,715,410
10 Day Avg. Volume1,517,633
30 Day Avg. Volume1,327,766
Standard Deviation0.16
R-Squared0.18
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.92
Price to Cash Flow (P/CF)20.80
P/FCF Ratio25.20
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue1.96
Enterprise Value/Gross Profit4.00
Enterprise Value/Ebitda-32.44
Forecast
1Y Price Target
$4.00Price Target Upside119.78% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Cerus News
PremiumCompany Announcements
Cerus Corporation Reports Strong Q3 2024 Financials
Bulls Say, Bears Say
Bulls Say
Financial PerformanceCERS is making progress towards profitability, reporting positive adjusted EBITDA in 3Q, a significant improvement from the previous year's loss.
Product Launch And Market ExpansionThe rollout of IFC continues to gain momentum, with sales driven by more standing orders and deeper utilization within existing accounts.
Strategic Partnerships And FundingCERS has entered into a new six-year agreement with BARDA to support the INTERCEPT RBC development program.
Bears Say
Approval DenialThe review of CERS' CE Mark application for INTERCEPT RBC has been completed without granting approval.
Data InsufficiencyThe company's application for INTERCEPT RBC had previously been under review by the EU Competent Authority, CBG, and concluded that the data are insufficient to support the proposed classification of the impurity profile of the final product.
Regulatory ChallengesThe review of CERS's CE Mark application for INTERCEPT RBC was completed without receiving approval, prompting the company to assess new strategies for regulatory submission.
---
Ownership Overview
15.94% Insiders
15.77% Mutual Funds
1.03% Other Institutional Investors
46.01% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CERS FAQ
What was Cerus Corporation’s price range in the past 12 months?
Cerus Corporation lowest stock price was $1.38 and its highest was $2.58 in the past 12 months.
What is Cerus Corporation’s market cap?
Cerus Corporation’s market cap is $338.00M.
When is Cerus Corporation’s upcoming earnings report date?
Cerus Corporation’s upcoming earnings report date is Feb 20, 2025 which is in 29 days.
How were Cerus Corporation’s earnings last quarter?
Cerus Corporation released its earnings results on Oct 30, 2024. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.032 by $0.012.
Is Cerus Corporation overvalued?
According to Wall Street analysts Cerus Corporation’s price is currently Undervalued.
Does Cerus Corporation pay dividends?
Cerus Corporation does not currently pay dividends.
What is Cerus Corporation’s EPS estimate?
Cerus Corporation’s EPS estimate is -0.01.
How many shares outstanding does Cerus Corporation have?
Cerus Corporation has 185,715,410 shares outstanding.
What happened to Cerus Corporation’s price movement after its last earnings report?
Cerus Corporation reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.032. Following the earnings report the stock price went down -8.721%.
Which hedge fund is a major shareholder of Cerus Corporation?
Currently, no hedge funds are holding shares in CERS
---
Cerus Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.00 (119.78% Upside)
$4.00 (119.78% Upside)
Hedge Fund Trend
Decreased
By 1.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $32.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.1%
Last 30 Days ▲ 5.9%
Last 30 Days ▲ 5.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.83%
12-Months-Change
Fundamentals
Return on Equity
-38.81%
Trailing 12-Months
Asset Growth
-7.92%
Trailing 12-Months
Company Description
Cerus Corporation
Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.
---
CERS Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong quarterly performance with positive trends in revenue growth and business expansion, particularly in the North American market and the INTERCEPT Fibrinogen Complex business. However, challenges such as a decline in government contract revenue and regulatory hurdles in Europe were noted. Overall, the positive aspects significantly outweigh the negatives, indicating a positive outlook.Read More>---
CERS Stock 12 Month Forecast
Average Price Target
$4.00
▲(119.78% Upside)
Technical Analysis
Celldex
―
ADMA Biologics
―
Karyopharm Therapeutics
―
Alaunos Therapeutics
―
Actinium Pharmaceuticals
―
Clearside Biomedical
―
Best Analysts Covering CERS
1 Year
1 Year Success Rate
5/17 ratings generated profit
1 Year Average Return
-11.80%
initiated a buy rating 9 days ago
Copying Josh Jennings's trades and holding each position for 1 Year would result in 29.41% of your transactions generating a profit, with an average return of -11.80% per trade.
---